In the backdrop of role of CDSCO, the country’s top drug regulator coming under the scanner in the wake of quality of drugs manufactured by three Indian pharma firms—Maiden Pharmaceuticals, Global Healthcare Pharma and Noida-based Marion Biotech-— coming in question, Union Health Minister Dr. Mansukh Mandaviya on Monday stressed on ensuring medicines and medical products produced in India are of the highest quality for both domestic and export markets. “Within the federal democratic structure of the country, both the Centre and States are required to work together in harmony and synergy to ensure that we establish robust regulatory systems,” he said at the concluding session of the two-days brainstorming conclave on “Drugs: Quality Regulations & Enforcement”, in Hyderabad, Telangana. The discussions highlighted how to make the country’s drug regulatory systems transparent, predictable and verifiable through principles of uniform standards, sturdy structures for compliance and enforcement, and capacity enhancement.
It was also presented that technology can play the role of a facilitator and enabler for uniformity, transparency and accountability. The need for a uniform portal with a national database with integrated legacy systems was also discussed.
